World federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care

WFSBP Task Force on Mental Disorders in Primary Care, WFSBP Task Force on Dementia

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Objective. To define a practice guideline for biological treatment of dementias for general practitioners in primary care. Methods. TThis paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Biological treatment of Alzheimer's disease and other dementias for treatment in primary care (Ihl et al. 2011). The recommendations were developed by a task force of international experts in the field and arc based on randomized controlled studies. Results. Anti-dementia medications neither cure, nor arrest, or alter the course of the disease. The type of dementia, the individual symptom constellation and the tolerability and evidence for efficacy should determine what medications should be used. In treating neuropsychiatrie symptoms, psychosocial intervention should be the treatment of first choice. For neuropsychiatrie symptoms, medications should only be considered when psychosocial interventions are not adequate and after cautious risk-benefit analysis. Conclusions. Depending on the diagnostic entity and clinical presentation different anti-dementia drugs can be recommended. These guidelines provide a practical approach for general practitioners managing dementias.

Original languageEnglish
Pages (from-to)2-7
Number of pages6
JournalInternational Journal of Psychiatry in Clinical Practice
Volume19
Issue number1
DOIs
Publication statusPublished - 2015 Mar 1
Externally publishedYes

Fingerprint

Biological Psychiatry
Dementia
Primary Health Care
Pharmacology
Guidelines
General Practitioners
Therapeutics
Advisory Committees
Practice Guidelines
Alzheimer Disease
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • Anti-dementia drugs
  • Dementia
  • Guidelines
  • Lewy body disease
  • Neuropsychiatric symptoms

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

World federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care. / WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Dementia.

In: International Journal of Psychiatry in Clinical Practice, Vol. 19, No. 1, 01.03.2015, p. 2-7.

Research output: Contribution to journalReview article

WFSBP Task Force on Mental Disorders in Primary Care ; WFSBP Task Force on Dementia. / World federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care. In: International Journal of Psychiatry in Clinical Practice. 2015 ; Vol. 19, No. 1. pp. 2-7.
@article{ea69241064e142b6bee60ee08b0ee9aa,
title = "World federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care",
abstract = "Objective. To define a practice guideline for biological treatment of dementias for general practitioners in primary care. Methods. TThis paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Biological treatment of Alzheimer's disease and other dementias for treatment in primary care (Ihl et al. 2011). The recommendations were developed by a task force of international experts in the field and arc based on randomized controlled studies. Results. Anti-dementia medications neither cure, nor arrest, or alter the course of the disease. The type of dementia, the individual symptom constellation and the tolerability and evidence for efficacy should determine what medications should be used. In treating neuropsychiatrie symptoms, psychosocial intervention should be the treatment of first choice. For neuropsychiatrie symptoms, medications should only be considered when psychosocial interventions are not adequate and after cautious risk-benefit analysis. Conclusions. Depending on the diagnostic entity and clinical presentation different anti-dementia drugs can be recommended. These guidelines provide a practical approach for general practitioners managing dementias.",
keywords = "Alzheimer's disease, Anti-dementia drugs, Dementia, Guidelines, Lewy body disease, Neuropsychiatric symptoms",
author = "{WFSBP Task Force on Mental Disorders in Primary Care} and {WFSBP Task Force on Dementia} and Ralf Ihl and Robertas Bunevicius and Lutz Fr{\"o}lich and Bengt Winblad and Schneider, {Lon S.} and Bruno Dubois and Alistair Burns and Florence Thibaut and Siegfried Kasper and M{\"o}ller, {Hans J{\"u}rgen} and Wioletta Baranska-Rybak and Cubała, {Wiesław Jerzy} and Jaanus Harro and Pop, {Victor J.M.} and Elmars Rancans and Jill Rasmussen and Zoltan Rihmer and Djea Saravane and Schlaepfer, {Thomas E.} and Leo Sher and Tang, {S. W.} and Leonas Valius and David Wong and Zhitnikova, {Larisa M.} and Joseph Zohar and Michel Benoit and Rafael Blesa and Henry Brodaty and Nancy Colimon and Islwan Degrell and Steve DeKosky and Engin Eker and Hidetoshi Endo and Timo Erkinjuntti and Hans F{\"o}rstl and Giovanni Frisoni and Serge Gauthier and Ezio Giacobini and Teresa Gomez-Isla and Goufries, {Carl Gerhard} and Michael Grundman and Changsu Han and Christoph Hock and Kulaksizoglu, {Isin Baral} and Josef Marksteiner and Colin Masters and Ian McKeith and Maria Olofsdottir and Michael Rainer and Barry Reisberg",
year = "2015",
month = "3",
day = "1",
doi = "10.3109/13651501.2014.961931",
language = "English",
volume = "19",
pages = "2--7",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - World federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care

AU - WFSBP Task Force on Mental Disorders in Primary Care

AU - WFSBP Task Force on Dementia

AU - Ihl, Ralf

AU - Bunevicius, Robertas

AU - Frölich, Lutz

AU - Winblad, Bengt

AU - Schneider, Lon S.

AU - Dubois, Bruno

AU - Burns, Alistair

AU - Thibaut, Florence

AU - Kasper, Siegfried

AU - Möller, Hans Jürgen

AU - Baranska-Rybak, Wioletta

AU - Cubała, Wiesław Jerzy

AU - Harro, Jaanus

AU - Pop, Victor J.M.

AU - Rancans, Elmars

AU - Rasmussen, Jill

AU - Rihmer, Zoltan

AU - Saravane, Djea

AU - Schlaepfer, Thomas E.

AU - Sher, Leo

AU - Tang, S. W.

AU - Valius, Leonas

AU - Wong, David

AU - Zhitnikova, Larisa M.

AU - Zohar, Joseph

AU - Benoit, Michel

AU - Blesa, Rafael

AU - Brodaty, Henry

AU - Colimon, Nancy

AU - Degrell, Islwan

AU - DeKosky, Steve

AU - Eker, Engin

AU - Endo, Hidetoshi

AU - Erkinjuntti, Timo

AU - Förstl, Hans

AU - Frisoni, Giovanni

AU - Gauthier, Serge

AU - Giacobini, Ezio

AU - Gomez-Isla, Teresa

AU - Goufries, Carl Gerhard

AU - Grundman, Michael

AU - Han, Changsu

AU - Hock, Christoph

AU - Kulaksizoglu, Isin Baral

AU - Marksteiner, Josef

AU - Masters, Colin

AU - McKeith, Ian

AU - Olofsdottir, Maria

AU - Rainer, Michael

AU - Reisberg, Barry

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Objective. To define a practice guideline for biological treatment of dementias for general practitioners in primary care. Methods. TThis paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Biological treatment of Alzheimer's disease and other dementias for treatment in primary care (Ihl et al. 2011). The recommendations were developed by a task force of international experts in the field and arc based on randomized controlled studies. Results. Anti-dementia medications neither cure, nor arrest, or alter the course of the disease. The type of dementia, the individual symptom constellation and the tolerability and evidence for efficacy should determine what medications should be used. In treating neuropsychiatrie symptoms, psychosocial intervention should be the treatment of first choice. For neuropsychiatrie symptoms, medications should only be considered when psychosocial interventions are not adequate and after cautious risk-benefit analysis. Conclusions. Depending on the diagnostic entity and clinical presentation different anti-dementia drugs can be recommended. These guidelines provide a practical approach for general practitioners managing dementias.

AB - Objective. To define a practice guideline for biological treatment of dementias for general practitioners in primary care. Methods. TThis paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Biological treatment of Alzheimer's disease and other dementias for treatment in primary care (Ihl et al. 2011). The recommendations were developed by a task force of international experts in the field and arc based on randomized controlled studies. Results. Anti-dementia medications neither cure, nor arrest, or alter the course of the disease. The type of dementia, the individual symptom constellation and the tolerability and evidence for efficacy should determine what medications should be used. In treating neuropsychiatrie symptoms, psychosocial intervention should be the treatment of first choice. For neuropsychiatrie symptoms, medications should only be considered when psychosocial interventions are not adequate and after cautious risk-benefit analysis. Conclusions. Depending on the diagnostic entity and clinical presentation different anti-dementia drugs can be recommended. These guidelines provide a practical approach for general practitioners managing dementias.

KW - Alzheimer's disease

KW - Anti-dementia drugs

KW - Dementia

KW - Guidelines

KW - Lewy body disease

KW - Neuropsychiatric symptoms

UR - http://www.scopus.com/inward/record.url?scp=84924036336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924036336&partnerID=8YFLogxK

U2 - 10.3109/13651501.2014.961931

DO - 10.3109/13651501.2014.961931

M3 - Review article

VL - 19

SP - 2

EP - 7

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 1

ER -